Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.

RTS,S Clinical Trials Partnership; (2014) Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS medicine, 11 (7). e1001685-. ISSN 1549-1277 DOI: https://doi.org/10.1371/journal.pmed.1001685

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1371/journal.pmed.1001685

Abstract

Share

Download

Filename: Efficacy and Safety of the RTSSAS01 Malaria Vaccine during 18 Months after Vaccination_GOLD VoR.pdf

Licence: Creative Commons: Public Domain Dedication

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar